BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Cipla
Colorcon
Healthtrust
Chubb
Chinese Patent Office
Express Scripts
Harvard Business School
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

Rose bengal sodium i-131 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rose bengal sodium i-131 and what is the scope of rose bengal sodium i-131 patent protection?

Rose bengal sodium i-131
is the generic ingredient in two branded drugs marketed by Bracco and Sorin, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for rose bengal sodium i-131.
Summary for rose bengal sodium i-131
Medical Subject Heading (MeSH) Categories for rose bengal sodium i-131

US Patents and Regulatory Information for rose bengal sodium i-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sorin SODIUM ROSE BENGAL I 131 rose bengal sodium i-131 INJECTABLE;INJECTION 017318-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Daiichi Sankyo
US Department of Justice
McKinsey
Cantor Fitzgerald
Cipla
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot